Seqens Seqens

X

Find Radio Compass News for MolPort-001-779-937

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

https://www.fiercepharma.com/pharma/gsk-was-warned-repeatedly-about-zantac-risks-didnt-act-warnings-bloomberg

Eric Sagonowsky FIERCE PHARMA
16 Feb 2023

https://recalls-rappels.canada.ca/en/alert-recall/apo-acyclovir-tablets-ndma-impurity

HEALTH CANADA
28 Jul 2022

https://www.europeanpharmaceuticalreview.com/news/172292/advancing-nitrosamines-analysis-with-gas-chromatography/

Hannah Balfour EUROPEANPHARMACEUTICALREVIEW
16 Jun 2022

https://www.europeanpharmaceuticalreview.com/news/171874/majority-of-metformin-drugs-have-acceptable-nitrosamine-levels-finds-study/

EUROPEANPHARMACEUTICALREVIEW
01 Jun 2022

https://www.newswire.ca/news-releases/advisory-apotex-recalls-apo-acyclovir-tablets-due-to-a-nitrosamine-impurity-831622325.html

NEWSWIRE
28 Apr 2022

http://www.koreabiomed.com/news/articleView.html?idxno=12902

KOREABIOMED
04 Jan 2022

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/viona-pharmaceuticals-inc-issues-voluntary-nationwide-recall-metformin-hcl-extended-release-tablets-0

FDA
29 Dec 2021

https://www.pharmacompass.com/pdf/news/viona-pharma-issues-voluntary-nationwide-recall-of-metformin-hcl-er-tablets-for-ndma-impurity-1623740019.pdf

FDA
15 Jun 2021

https://www.pharmacompass.com/pdf/news/health-canada-pharmascience-increcalls-of-pms-ranitidine-150mg-1612589331.pdf

HEALTH CANADA
05 Feb 2021

https://www.tribuneindia.com/news/business/indian-drug-firms-recall-various-products-in-us-market-170632

TRIBUNEINDIA
13 Nov 2020

https://www.pharmacompass.com/pdf/news/nostrum-laboratories-inc-issues-voluntary-nationwide-recall-of-metformin-hcl-extended-release-tablets-usp-750-mg-1604410216.pdf

FDA
03 Nov 2020

https://www.pharmacompass.com/pdf/news/marksans-pharma-limited-issues-expansion-of-voluntary-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-1601968692.pdf

FDA
06 Oct 2020

https://www.slashgear.com/popular-diabetes-drug-recalled-months-after-fda-issued-cancer-risk-warning-27640043/

B. A. Roston SLASHGEAR
28 Sep 2020

https://www.pharmacompass.com/pdf/news/sun-pharmaceutical-issues-recall-of-riometer-due-to-ndma-content-higher-than-adi-limit-1601355298.pdf

FDA
28 Sep 2020

https://www.pharmacompass.com/pdf/news/sun-pharmaceutical-industries-inc-issues-voluntary-nationwide-recall-of-riomet-er-metformin-hydrochloride-for-extended-release-oral-suspension-1601968935.pdf

FDA
24 Sep 2020

https://www.biospace.com/article/releases/sun-pharmaceutical-industries-inc-issues-voluntary-nationwide-recall-of-riomet-er-metformin-hydrochloride-for-extended-release-oral-suspension-due-to-n-nitrosodimethylamine-ndma-content-above-the-acceptable-daily-intake-adi-limit/

BIOSPACE
22 Sep 2020

https://www.fda.gov/news-events/press-announcements/fda-provides-guidance-industry-detecting-and-preventing-nitrosamines-drugs

FDA
02 Sep 2020

https://www.pharmacompass.com/pdf/news/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-1594396507.pdf

FDA
10 Jul 2020

https://www.pharmacompass.com/pdf/news/granules-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-1594102684.pdf

FDA
07 Jul 2020

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-one-lot-metformin-hydrochloride

FDA
12 Jun 2020

https://www.pharmacompass.com/pdf/news/marksans-pharma-limited-issues-voluntary-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-1591423317.pdf

FDA
06 Jun 2020

https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticals-bridgewater-new-jersey-amneal-is-voluntarily-recalling-all-lots-of-metformin-hydrochloride-extended-release-tablets-usp-500-mg-and-750-mg-within-expiry-to-the-retail-level-1591090849.pdf

FDA
02 Jun 2020

https://www.thehindu.com/news/international/usfda-for-recall-of-diabetes-drug-metformin-after-tests-find-high-levels-of-carcinogen/article31707744.ece

THEHINDU
01 Jun 2020

https://www.pharmacompass.com/pdf/news/apotex-corp-issues-voluntary-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-500mg-due-to-the-detection-of-n-nitrosodimethylamine-ndma-1590747013.pdf

FDA
29 May 2020

https://www.ndtv.com/world-news/us-food-and-drug-administration-asks-5-firms-to-recall-diabetes-drug-metformin-over-carcinogen-concerns-2236974

NDTV
28 May 2020

https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticals-issues-voluntary-nationwide-recall-of-nizatidine-oral-solution-1587013187.pdf

FDA
16 Apr 2020

https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticalsissues-voluntary-nationwide-recall-of-nizatidine-oral-solution-1587446824.pdf

FDA
16 Apr 2020

https://www.business-standard.com/article/companies/aurobindo-pharma-faces-class-action-suit-in-us-for-concealing-facts-120040701355_1.html

BUSINESS-STANDARD
08 Apr 2020

https://www.ema.europa.eu/en/news/update-nitrosamines-eu-medicines

EMA
04 Mar 2020

https://www.pharmacompass.com/pdf/news/american-health-packaging-issues-voluntary-nationwide-recall-of-ranitidine-tablets-1582867140.pdf

FDA
28 Feb 2020

https://markets.businessinsider.com/news/stocks/information-update-certain-metformin-diabetes-drugs-recalled-due-to-the-presence-of-ndma-1028942508

BUSINESSINSIDER
27 Feb 2020

https://www.raps.org/news-and-articles/news-articles/2020/2/ndma-in-metformin-fda-finds-low-levels-in-only-2

Zachary Brennan RAPS
03 Feb 2020

https://www.fiercepharma.com/manufacturing/more-generic-zantac-recalled-as-ndma-contamination-concerns-build

Eric Palmer FIERCE PHARMA
13 Jan 2020

https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutical-ingredient-manufactured-by-s-300983578.html

PR NEWSWIRE
08 Jan 2020

https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutical-ingredient-manufactured-by-s-300983578.html

PR NEWSWIRE
07 Jan 2020

https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutical-ingredient-manufactured-by-s-300983578.html

PR NEWSWIRE
07 Jan 2020

https://www.tga.gov.au/alert/metformin

TGA
12 Dec 2019

https://www.fiercepharma.com/manufacturing/after-zantac-scare-regulators-turn-to-generic-metformin-for-carcinogen-tests

Kyle Blankenship FIERCE PHARMA
07 Dec 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-4-2019-1575442774.pdf

FDA
04 Dec 2019

https://www.hsa.gov.sg/announcements/news/hsa-recalls-three-out-of-46-metformin-medicines

HSA
04 Dec 2019

http://www.pharmabiz.com/NewsDetails.aspx?aid=119722&sid=1

Yash Ved PHARMABIZ
03 Dec 2019

https://www.business-standard.com/article/news-cm/solara-active-pharma-sciences-update-on-ranitidine-hydrochloride-nizatidine-api-119110400595_1.html

BUSINESS-STANDARD
25 Nov 2019

https://www.raps.org/news-and-articles/news-articles/2019/11/contamination-potential-leads-uk-to-fifth-recall-o

M. Mezher RAPS
22 Nov 2019

https://www.pharmacompass.com/pdf/news/golden-state-medical-supply-issues-a-voluntary-nationwide-recall-of-ranitidine-hydrochloride-1574235383.pdf

FDA
20 Nov 2019

https://www.pharmacompass.com/pdf/news/precision-dose-inc-issues-voluntary-nationwide-recall-of-ranitidine-oral-solution-1574235567.pdf

FDA
20 Nov 2019

https://www.fiercepharma.com/manufacturing/mylan-plant-knocked-for-inadequate-manufacturing-controls-tainted-valsartan-fiasco

K. Blankenship FIERCE BIOTCH
14 Nov 2019

https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticals-issues-voluntary-nationwide-recall-of-ranitidine-tablets-1573624886.pdf

FDA
13 Nov 2019

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-relaunches-ranitidine-tablets-in-us/articleshow/71968842.cms

ECONOMIC TIMES
08 Nov 2019

https://www.washingtonpost.com/science/a-tiny-pharmacy-is-identifying-big-problems-with-common-drugs-including-zantac/2019/11/08/6dd009ca-eb76-11e9-9c6d-436a0df4f31d_story.html

C. Y. Johnson THE WASHINGTON POST
08 Nov 2019

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aurobindo-pharma-usa-inc-initiates-voluntary-nationwide-consumer-level-recall-38-lots-ranitidine

FDA
08 Nov 2019
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY